Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua F Baker

Showing results (91-100 of 245) with videos related to

Pageof 25
Sort By:
Arthritis Care & Research|September 25, 2019
Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early Rheumatoid Arthritis With Poor PrognosisHarris A Ahmad, Joshua F Baker, Mikkel Østergaard, et al.
Arthritis Research & Therapy|September 9, 2023
Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA RegistryDimitrios A Pappas, Jacqueline O'Brien, Lin Guo, et al.
Rheumatology International|January 20, 2011
Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcificationJoshua F Baker, Lifeng Zhang, Sotonye Imadojemu, et al.
World Journal of Diabetes|March 14, 2018
Blood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritisPatrick R Wood, Evan Manning, Joshua F Baker, et al.
Clinical Rheumatology|November 25, 2020
Evaluation of the impact of age and adiposity on a multi-biomarker disease activity score before and after adjustmentJoshua F Baker, Jeffrey R Curtis, David Chernoff, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Development and validation of modified disease activity scores in rheumatoid arthritis: superior correlation with magnetic resonance imaging-detected synovitis and radiographic progressionJoshua F Baker, Philip G Conaghan, Josef S Smolen, et al.
Arthritis Care & Research|January 28, 2017
Perioperative Timing of Infliximab and the Risk of Serious Infection After Elective Hip and Knee ArthroplastyMichael D George, Joshua F Baker, Jesse Yenchih Hsu, et al.
The American Journal of Medicine|July 18, 2012
Vitamin D, metabolic dyslipidemia, and metabolic syndrome in rheumatoid arthritisJoshua F Baker, Nehal N Mehta, Daniel G Baker, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 23, 2011
Development and evaluation of a survey of gout patients concerning their knowledge about goutLi Yun Zhang, H Ralph Schumacher, Hou Heng Su, et al.
The Journal of Rheumatology|September 3, 2011
Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcificationJoshua F Baker, Megan Morales, Mohammed Qatanani, et al.
Pageof 25

Showing results (91-100 of 245) with videos related to

Sort By:
Pageof 25
Arthritis Care & Research|September 25, 2019
Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early Rheumatoid Arthritis With Poor PrognosisHarris A Ahmad, Joshua F Baker, Mikkel Østergaard, et al.
Arthritis Research & Therapy|September 9, 2023
Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA RegistryDimitrios A Pappas, Jacqueline O'Brien, Lin Guo, et al.
Rheumatology International|January 20, 2011
Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcificationJoshua F Baker, Lifeng Zhang, Sotonye Imadojemu, et al.
World Journal of Diabetes|March 14, 2018
Blood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritisPatrick R Wood, Evan Manning, Joshua F Baker, et al.
Clinical Rheumatology|November 25, 2020
Evaluation of the impact of age and adiposity on a multi-biomarker disease activity score before and after adjustmentJoshua F Baker, Jeffrey R Curtis, David Chernoff, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Development and validation of modified disease activity scores in rheumatoid arthritis: superior correlation with magnetic resonance imaging-detected synovitis and radiographic progressionJoshua F Baker, Philip G Conaghan, Josef S Smolen, et al.
Arthritis Care & Research|January 28, 2017
Perioperative Timing of Infliximab and the Risk of Serious Infection After Elective Hip and Knee ArthroplastyMichael D George, Joshua F Baker, Jesse Yenchih Hsu, et al.
The American Journal of Medicine|July 18, 2012
Vitamin D, metabolic dyslipidemia, and metabolic syndrome in rheumatoid arthritisJoshua F Baker, Nehal N Mehta, Daniel G Baker, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 23, 2011
Development and evaluation of a survey of gout patients concerning their knowledge about goutLi Yun Zhang, H Ralph Schumacher, Hou Heng Su, et al.
The Journal of Rheumatology|September 3, 2011
Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcificationJoshua F Baker, Megan Morales, Mohammed Qatanani, et al.
Pageof 25